• 1
    Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK: Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988; 158:819828.
  • 2
    Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE: The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34:864869.
  • 3
    Kenyon C, Colebunders R, Crucitti T: The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 2013; 209:505523.
  • 4
    Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:18631868.
  • 5
    Taha TE, Gray RH, Kumwenda NI, Hoover DR, Mtimavalye LA, Liomba GN, Chiphangwi JD, Dallabetta GA, Miotti PG: HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:5259.
  • 6
    Cohen CR, Lingappa JR, Baeten JM, Ngayo MA, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukisi EA: Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012; 9:e1001251.
  • 7
    Mirmonsef P, Krass L, Landay A, Spear GT: The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res 2012; 10:202210.
  • 8
    Thurman AR, Doncel GF: Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol 2011; 65:8998.
  • 9
    Carias AM, McCoombe S, McRaven M, Anderson M, Galloway N, Vadergrift N, Fought AJ, Lurain J, Duplantis M, Veazey RS, Hope TJ: Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol 2013; 87:1138811400.
  • 10
    Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, McElrath MJ: Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26:257270.
  • 11
    Kaushic C, Ferreira VH, Kafka JK, Nazli A: HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment. Am J Reprod Immunol 2010; 63:566575.
  • 12
    Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC: Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis 2012; 206:19311935.
  • 13
    Lajoie J, Juno J, Burgener A, Rahman S, Mogk K, Wachihi C, Mwanjewe J, Plummer FA, Kimani J, Ball TB, Fowke KR: A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol 2012; 5:277287.
  • 14
    Yao XD, Omange RW, Henrick BM, Lester RT, Kimani J, Ball TB, Plummer FA, Rosenthal KL: Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers. Mucosal Immunol 2014; 7:268279.
  • 15
    Morrison C, Fichorova R, Mauck C, Chen P, Kwok C, Chipato T, Salata R, Doncel GF: Cervical inflammation and immunity associated with hormonal contraception, pregnancy and HIV-1 seroconversion. J Acquir Immune Defic Syndr 2014. [Epub ahead of print].
  • 16
    de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB: TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 2008; 118:34403452.
  • 17
    Martius J, Krohn MA, Hillier SL, Stamm WE, Holmes KK, Eschenbach DA: Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988; 71:8995.
  • 18
    Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlenbach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ: Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2010; 108(Suppl 1):46804687.
  • 19
    Marrazzo JM, Martin DH, Watts DH, Schulte J, Sobel JD, Hillier SL, Deal C, Fredricks DN: Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis 2010; 37:732744.
  • 20
    Eaton KA, Honkala A, Auchtung TA, Britton RA: Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect Immun 2011; 79:185191.
  • 21
    Castillo NA, de Moreno de LeBlanc A, Galdeano CM, Perdigon G: Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli. J Appl Microbiol 2013; 114:861876.
  • 22
    Nikolaitchouk N, Andersch B, Falsen E, Strombeck L, Mattsby-Baltzer I: The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). APMIS 2008; 116:263277.
  • 23
    Orfanelli T, Jayaram A, Doulaveris G, Forney LJ, Ledger WJ, Witkin SS: Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition. Reprod Sci 2014; 21:538542.
  • 24
    Sakai M, Ishiyama A, Tabata M, Sasaki Y, Yoneda S, Shiozaki A, Saito S: Relationship between cervical mucus interleukin-8 concentrations and vaginal bacteria in pregnancy. Am J Reprod Immunol 2004; 52:106112.
  • 25
    Kyongo JK, Jespers V, Goovaerts O, Michiels J, Menten J, Fichorova RN, Crucitti T, Vanham G, Arien KK: Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PLoS ONE 2012; 7:e43951.
  • 26
    Alvarez-Olmos MI, Barousse MM, Rajan L, Van Der Pol BJ, Fortenberry D, Orr D, Fidel PL Jr: Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis 2004; 31:393400.
  • 27
    Srinivasan S, Hoffman NG, Morgan MT, Matsen FA, Fiedler TL, Hall RW, Ross FJ, McCoy CO, Bumgarner R, Marrazzo JM, Fredricks DN: Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 2012; 7:e37818.
  • 28
    Culhane JF, Nyirjesy P, McCollum K, Goldenberg RL, Gelber SE, Cauci S: Variation in vaginal immune parameters and microbial hydrolytic enzymes in bacterial vaginosis positive pregnant women with and without Mobiluncus species. Am J Obstet Gynecol 2006; 195:516521.
  • 29
    Allsworth JE, Peipert JF: Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol 2011; 205:113 e111–116.
  • 30
    Srinivasan S, Morgan MT, Liu C, Matsen FA, Hoffman NG, Fiedler TL, Agnew KJ, Marrazzo JM, Fredricks DN: More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS ONE 2013; 8:e78633.
  • 31
    Lambert JA, John S, Sobel JD, Akins RA: Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process. PLoS ONE 2013; 8:e82599.
  • 32
    Ravel J, Brotman RM, Gajer P, Ma B, Nandy M, Fadrish DW, Sakamoto J, Koenig SS, Fu L, Zhou X, Hickey RJ, Schwebke JR, Forney LJ: Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 2013; 1:29.
  • 33
    Schwebke JR, Morgan SC, Weiss HL: The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora. Sex Transm Dis 1997; 24:236239.
  • 34
    Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN: Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 2010; 5:e10197.
  • 35
    Macklaim JM, Fernandes AD, Di Bella JM, Hammond JA, Reid G, Gloor GB: Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 2013; 1:12.
  • 36
    Bump RC, Zuspan FP, Buesching WJ III, Ayers LW, Stephens TJ: The prevalence, six-month persistence, and predictive values of laboratory indicators of bacterial vaginosis (nonspecific vaginitis) in asymptomatic women. Am J Obstet Gynecol 1984; 150:917924.
  • 37
    Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay AL, Spear GT: Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol 2012; 67:391400.
  • 38
    Balkus J, Agnew K, Lawler R, Mitchell C, Hitti J: Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions. J Pregnancy 2010; 2010:385981.
  • 39
    Beigi RH, Yudin MH, Cosentino L, Meyn LA, Hillier SL: Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis 2007; 196:13551360.
  • 40
    Cherpes TL, Marrazzo JM, Cosentino LA, Meyn LA, Murray PJ, Hillier SL: Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex Transm Infect 2008; 84:5761.
  • 41
    Losikoff P, Fichorova R, Snyder B, Rodriguez I, Cu-Uvin S, Harwell J, Mayer KH: Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women. Infect Dis Obstet Gynecol 2007; 2007:92307.
  • 42
    Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J: Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. J Women's Health (Larchmt) 2009; 18:18171824.
  • 43
    Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, Ball TB, Plummer FA, Jaoko W, Kaul R: Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008; 49:520522.
  • 44
    Valore EV, Wiley DJ, Ganz T: Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006; 74:56935702.
  • 45
    Yudin MH, Landers DV, Meyn L, Hillier SL: Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003; 102:527534.
  • 46
    Marconi C, Donders GG, Parada CM, Giraldo PC, da Silva MG: Do Atopobium vaginae, Megasphaera sp. and Leptotrichia sp. change the local innate immune response and sialidase activity in bacterial vaginosis? Sex Transm Infect 2013; 89:167173.
  • 47
    Mitchell C, Gottsch ML, Liu C, Fredricks DN, Nelson DB: Associations between vaginal bacteria and levels of vaginal defensins in pregnant women. Am J Obstet Gynecol 2013; 208:132 e131–137.
  • 48
    Libby EK, Pascal KE, Mordechai E, Adelson ME, Trama JP: Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis. Microbes Infect 2008; 10:439446.
  • 49
    Fichorova RN, Buck OR, Yamamoto HS, Fashemi T, Dawood HY, Fashemi B, Hayes GR, Beach DH, Takagi Y, Delaney ML, Nibert ML, Singh BN, Onderdonk AB: The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect 2013; 89:460466.
  • 50
    Eade CR, Diaz C, Wood MP, Anastos K, Patterson BK, Gupta P, Cole AL, Cole AM: Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay. PLoS ONE 2012; 7:e50106.
  • 51
    Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229241.
  • 52
    Rose WA II, McGowin CL, Spagnuolo RA, Eaves-Pyles TD, Popov VL, Pyles RB: Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PLoS ONE 2012; 7:e32728.
  • 53
    Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Vaginal microbiota alter the innate immune and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis 2014. [Epub ahead of print].
  • 54
    Rizzo A, Losacco A, Carratelli CR: Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human beta-defensins 2 and 3. Immunol Lett 2013; 156:102109.
  • 55
    Genc MR, Onderdonk AB, Vardhana S, Delaney ML, Norwitz ER, Tuomala RE, Paraskevas LR, Witkin SS: Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol 2004; 191:13241330.
  • 56
    Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E, Witkin SS: Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004; 116:152156.
  • 57
    Goepfert AR, Varner M, Ward K, Macpherson C, Klebanoff M, Goldenberg RL, Mercer B, Meis P, Iams J, Moawad A, Carey JC, Leveno K, Wapner R, Caritis SN, Miodovnik M, Sorokin Y, O'Sullivan MJ, Van Dorsten JP, Langer O: Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy. Am J Obstet Gynecol 2005; 193:14781485.
  • 58
    Gomez LM, Sammel MD, Appleby DH, Elovitz MA, Baldwin DA, Jeffcoat MK, Macones GA, Parry S: Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol 2010; 202:386 e381–386.
  • 59
    Giraldo PC, de Carvalho JB, do Amaral RL, da Silveira Goncalves AK, Eleuterio J Jr, Guimaraes F: Identification of immune cells by flow cytometry in vaginal lavages from women with vulvovaginitis and normal microflora. Am J Reprod Immunol 2012; 67:198205.
  • 60
    Marrazzo JM, Wiesenfeld HC, Murray PJ, Busse B, Meyn L, Krohn M, Hillier SL: Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 2006; 193:617624.
  • 61
    Taylor BD, Darville T, Haggerty CL: Does bacterial vaginosis cause pelvic inflammatory disease? Sex Transm Dis 2013; 40:117122.
  • 62
    Anton G, Rid J, Mylonas I, Friese K, Weissenbacher ER: Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis. Infection 2008; 36:147152.
  • 63
    Cauci S, Guaschino S, De Aloysio D, Driussi S, De Santo D, Penacchioni P, Quadrifoglio F: Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003; 9:5358.
  • 64
    Cauci S, Guaschino S, Driussi S, De Santo D, Lanzafame P, Quadrifoglio F: Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J Infect Dis 2002; 185:16141620.
  • 65
    Mattsby-Baltzer I, Platz-Christensen JJ, Hosseini N, Rosen P: IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand 1998; 77:701706.
  • 66
    Sturm-Ramirez K, Gaye-Diallo A, Eisen G, Mboup S, Kanki PJ: High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis 2000; 182:467473.
  • 67
    Basso B, Gimenez F, Lopez C: IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect Dis Obstet Gynecol 2005; 13:207211.
  • 68
    Campos AC, Murta EF, Michelin MA, Reis C: Evaluation of cytokines in endocervical secretion and vaginal pH from women with bacterial vaginosis or Human Papillomavirus. ISRN Obstet Gynecol 2012; 2012:342075.
  • 69
    Fan SR, Liu XP, Liao QP: Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis. Int J Gynaecol Obstet 2008; 103:5054.
  • 70
    Ryckman KK, Williams SM, Krohn MA, Simhan HN: Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis. J Reprod Immunol 2008; 78:166171.
  • 71
    Weissenbacher T, Walter C, Mylonas I, Scholz C, Gingelmaier A, Friese K: Interleukin-6, interleukin-10 and interleukin-12 in vaginal fluid from women with bacterial vaginosis. Arch Gynecol Obstet 2010; 281:7780.
  • 72
    Tavares-Murta BM, de Resende AD, Cunha FQ, Murta EF: Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol 2008; 138:9399.
  • 73
    Hedges SR, Barrientes F, Desmond RA, Schwebke JR: Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 2006; 193:556562.
  • 74
    Spandorfer SD, Neuer A, Giraldo PC, Rosenwaks Z, Witkin SS: Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J Reprod Med 2001; 46:806810.
  • 75
    Nenadic DB, Pavlovic MD: Cervical fluid cytokines in pregnant women: relation to vaginal wet mount findings and polymorphonuclear leukocyte counts. Eur J Obstet Gynecol Reprod Biol 2008; 140:165170.
  • 76
    Diaz-Cueto L, Cuica-Flores A, Ziga-Cordero F, Arechavaleta-Velasco ME, Arechavaleta-Velasco F: Genetic variation in the interleukin-8 gene promoter and vaginal concentrations of interleukin-8 are not associated with bacterial vaginosis during pregnancy. J Reprod Immunol 2005; 66:151160.
  • 77
    Yasodhara P, Raghunath M, Sreeramulu D, Venu L, Hemalatha R, Krishna TP: Local immunity in Indian women with bacterial vaginosis. J Reprod Immunol 2006; 70:133141.
  • 78
    Cohen CR, Plummer FA, Mugo N, Maclean I, Shen C, Bukusi EA, Irungu E, Sinei S, Bwayo J, Brunham RC: Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999; 13:327332.
  • 79
    Novak RM, Donoval BA, Graham PJ, Boksa LA, Spear G, Hershow RC, Chen HY, Landay A: Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol 2007; 14:11021107.
  • 80
    Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP: Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000; 183:12431248.
  • 81
    Xu J, Holzman CB, Arvidson CG, Chung H, Goepfert AR: Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. Obstet Gynecol 2008; 112:524531.
  • 82
    Sawada M, Otsuki K, Mitsukawa K, Yakuwa K, Nagatsuka M, Okai T: Cervical inflammatory cytokines and other markers in the cervical mucus of pregnant women with lower genital tract infection. Int J Gynaecol Obstet 2006; 92:117121.